文献速递白血病

circFAM193B与PRMT6相互作用通过改变氧化代谢和脂质过氧化调控急性髓系白血病干细胞的化疗耐药

circFAM193B interaction with PRMT6 regulates AML leukemia stem cells chemoresistance through altering the oxidative metabolism and lipid peroxidation.
PubMed 文献 · Leukemia · 2024-02-29

研究鉴定出circFAM193B调控白血病干细胞(LSC)的氧化还原生物学,并与AML患者不良预后相关。体外和体内实验提示circFAM193B显著抑制LSC化疗耐药和AML进展。机制上circFAM193B与PRMT6催化结构域结合,通过降低H3R2me2a修饰增强ALOX15转录效率。

要点

  • circFAM193B在LSC中下调,与AML患者不良预后相关。
  • 敲低circFAM193B增强线粒体OXPHOS并抑制化疗介导的活性氧和脂质过氧化积累,保护AML细胞免受氧化应激诱导的死亡。
  • circFAM193B与PRMT6催化结构域结合,通过降低H3R2me2a修饰增强ALOX15转录效率。

核心结论

  • circFAM193B在LSC中下调,通过调控能量代谢和氧化还原平衡促进化疗后LSC持续存活。
  • 研究为circRNA介导的PRMT6沉积甲基精氨酸信号参与LSC耐药提供了概念进展和生物学见解。

研究设计与样本

  • 研究采用体外和体内实验,鉴定circFAM193B对LSC化疗耐药和AML进展的调控作用。

主要发现

  • circFAM193B与AML患者不良预后相关。
  • 体外和体内实验提示circFAM193B显著抑制LSC化疗耐药和AML进展。
  • 敲低circFAM193B增强线粒体OXPHOS功能并抑制化疗介导的活性氧和脂质过氧化积累,从而保护AML细胞免受氧化应激诱导的细胞死亡。
  • circFAM193B与精氨酸甲基转移酶PRMT6催化结构域物理结合,通过降低H3R2me2a修饰增强关键脂质过氧化因子ALOX15的转录效率。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Most forms of chemotherapy for acute myeloid leukemia (AML) are often ineffective in eliminating leukemic stem cells (LSCs), as their underlying mechanisms remain unclear. Here, we have identified circFAM193B, which regulates the redox biology of LSCs and is associated with unfavorable outcomes in AML patients. In vitro and in vivo assays suggested that circFAM193B significantly inhibits LSCs chemotherapy resistance and AML progression. Knockdown circFAM193B enhances mitochondrial OXPHOS function and inhibits the accumulation of reactive oxygen species and lipid peroxidation mediated by chemotherapy, which protects AML cells from oxidative stress-induced cell death. Mechanistically, circFAM193B physically interacts with arginine methyltransferase PRMT6 catalytic domain and enhances the transcription efficiency of key lipid peroxidation factor ALOX15 by decreasing H3R2me2a modification. In summary, we have identified circFAM193B was downregulated in LSCs to promote the survival of LSC by modulating energy metabolism and the redox balance in the postchemotherapy persistence of LSC. Our studies provide a conceptual advance and biological insights regarding the drug resistance of LSCs via circRNA mediated PRMT6-deposited methylarginine signaling.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Yang X, Liu J, Liu W, et al. circFAM193B interaction with PRMT6 regulates AML leukemia stem cells chemoresistance through altering the oxidative metabolism and lipid peroxidation. Leukemia. 2024. PMID: 38424136. doi:10.1038/s41375-024-02189-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。